Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | NQO2 | P16083 | 1/20 | 0.43 |
| ▸ | CASP6 | P55212 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | NQO1 | P15559 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30364741 | 1.00 | TRPM4 (0.50) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL4172887 | 0.84 | LMNA (0.54) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL15485758 | 0.83 | NQO1 (0.50) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL9233004 | 0.83 | TRPM4 (0.61) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL30071634 | 0.83 | LMNA (0.52) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL29771816 | 0.83 | TRPM4 (0.61) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL3953630 | 0.83 | LMNA (0.52) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL28848790 | 0.82 | CYP1A2 (0.54) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL23110575 | 0.82 | CYP1A2 (0.44) | TRPM4CYP1A2CYP2A6ALDH1A1HSD17B10 | |
| SCHEMBL15910812 | 0.82 | ALDH1A1 (0.50) | CYP1A2CYP2A6ALDH1A1HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250011655-A1 | RENEWABLE JET PRODUCTION FROM CATALYTIC PYROLYSIS FEEDSTOCK | IFP Energies Nouvelles (FR) | 2025-01-09 | — | — | US | claimed |
| EP-4433553-A1 | RENEWABLE JET PRODUCTION FROM CATALYTIC PYROLYSIS FEEDSTOCK | IFP Energies nouvelles (FR) | 2024-09-25 | — | — | EP | claimed |
| WO-2023088772-A1 | RENEWABLE JET PRODUCTION FROM CATALYTIC PYROLYSIS FEEDSTOCK | IFP Energies Nouvelles (FR) | 2023-05-25 | — | — | WO | claimed |
| US-10364322-B2 | Naphthalene-containing polymers and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2019-07-30 | — | — | US | claimed |
| US-20180208716-A1 | NAPHTHALENE-CONTAINING POLYMERS AND METHODS OF MAKING THE SAME | Alliance for Energy Innovation, LLC | 2018-07-26 | — | — | US | claimed |
| CN-101448771-B | Patchouli odorant | FIRMENICH & CIE | 2012-03-21 | — | — | CN | claimed |
| EP-1841723-A1 | DECALINE DERIVED COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS | Universität Dortmund (DE) | 2007-10-10 | — | — | EP | claimed |
| WO-2006069787-A1 | DECALINE-DERIVED COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS | Universität Dortmund (DE) | 2006-07-06 | — | — | WO | claimed |
| JP-10316625-A | — | — | None | — | — | JP | disclosed |
| US-20250282945-A1 | CURABLE RESIN COMPOSITION AND ELECTRONIC COMPONENT DEVICE | RESONAC CORPORATION (JP) | 2025-09-11 | — | — | US | disclosed |
| CN-120059458-A | Resin composition | 味之素株式会社 | 2025-05-30 | — | — | CN | disclosed |
| CN-119859380-A | Resin composition | 味之素株式会社 | 2025-04-22 | — | — | CN | disclosed |
| CN-119639227-A | Resin composition | 味之素株式会社 | 2025-03-18 | — | — | CN | disclosed |
| CN-119552478-A | Resin composition | 味之素株式会社 | 2025-03-04 | — | — | CN | disclosed |
| US-4097461-A | Oxidative coupling of alkylphenols or 1-naphthols catalyzed by metal complexes of diketo compounds | ICI AMERICAS INC. (US) | 1978-06-27 | — | — | US | disclosed |
| US-4096190-A | Oxidative coupling of alkylphenols catalyzed by metal ammonia complexes | ICI AMERICAS INC. (US) | 1978-06-20 | — | — | US | disclosed |
| US-4085124-A | Oxidative coupling of alkylphenols, alkoxyphenols and 1-naphthols catalyzed by metal complexes of amino compounds | ICI AMERICAS INC. (US) | 1978-04-18 | — | — | US | disclosed |
| US-4070383-A | COPPER COMPOUND-ANIONIC SURFACTANT-ALKALI METAL COMPOUND CATALYST SYSTEM | ICI AMERICAS INC. (US) | 1978-01-24 | — | — | US | disclosed |
| US-4067890-A | Oxidative coupling of alkylphenols, alkoxyphenols and naphthols catalyzed by metal complexes of amino carboxylic and amino sulfonic acids | ICI AMERICA INC. (US) | 1978-01-10 | — | — | US | disclosed |
| US-3987068-A | COPPER-NITRILE COMPLEX CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180208716-A1 | NAPHTHALENE-CONTAINING POLYMERS AND METHODS OF MAKING THE SAME | NCL, NUCB2, NOC2L | TRPM4 4859/4885CYP1A2 556/4885CYP2A6 1823/4885 |
| US-10364322-B2 | Naphthalene-containing polymers and methods of making the same | NCL, NUCB2, NOC2L | TRPM4 4859/4885CYP1A2 556/4885CYP2A6 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.